FDA Inspection 1068341 — American Red Cross Biomedical Services Northern New England Region
The FDA completed an inspection of American Red Cross Biomedical Services Northern New England Region on September 13, 2018 in Burlington, VT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 13, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Burlington, VT (United States)